The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Dendritic cells as shepherds of T cell immunity in cancer
Open accessAbstract
In cancer patients, dendritic cells (DCs) in tumor-draining lymph nodes can present antigens to naive T cells in ways that break immunological tolerance. The clonally expanded progeny of primed T cells are further regulated by DCs at tumor sites. Intra-tumoral DCs can both provide survival signals to and drive effector differentiation of incoming T cells, thereby locally enhancing antitumor immunity; however, the paucity of intra-tumoral DCs or their expression of immunoregulatory molecules often limits anti-tumor T cell responses. Here we review the current understanding of DC-T cell interactions at both priming and effector sites of immune responses. We place emerging insights into DC functions in tumor immunity in the context of DC development, ontogeny, and functions in other settings, and propose that DCs control at least two T-cell-associated checkpoints of the cancer immunity cycle. Our understanding of both checkpoints has implications for the development of new approaches to cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Samstein, R. M., Lee, C.-H., Shoushtari, A. N., Hellmann, M. D., Shen, R., Janjigian, Y. Y., Barron, D. A., Zehir, A., Jordan, E. J., Omuro, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0312-8 · Cited by 4,071
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., et al. (2017) · Science · doi:10.1126/science.aah4573 · Cited by 2,413
Control of adaptive immunity by the innate immune system
Iwasaki, A., & Medzhitov, R. (2015) · Nature Immunology · doi:10.1038/ni.3123 · Cited by 2,160
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
Mempel, T. R., Henrickson, S. E., & von Andrian, U. H. (2004) · Nature · doi:10.1038/nature02238 · Cited by 1,714
Self-citationA pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.010 · Cited by 1,601
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., Xu, C., McKenzie, J. A., Zhang, C., Liang, X., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0283 · Cited by 1,539
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
Zhang, L., Li, Z., Skrzypczynska, K. M., Fang, Q., Zhang, W., O’Brien, S. A., He, Y., Wang, L., Zhang, Q., Kim, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.048 · Cited by 1,526
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I., Maroni, G., Meyerovitz, C. V., Kerwin, C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.009 · Cited by 1,475
Self-citationSpranger, S., Dai, D., Horton, B., & Gajewski, T. F. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.003 · Cited by 1,441
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node
Miller, M. J., Wei, S. H., Parker, I., & Cahalan, M. D. (2002) · Science · doi:10.1126/science.1070051 · Cited by 1,207
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Tertiary lymphoid structures in cancer
Schumacher, T. N., & Thommen, D. S. (2022) · Science · doi:10.1126/science.abf9419 · Cited by 1,142
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Zelenay, S., van der Veen, A. G., Böttcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., Chakravarty, P., Girotti, M. R., Marais, R., Quezada, S. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.015 · Cited by 1,128
Roberts, E. W., Broz, M. L., Binnewies, M., Headley, M. B., Nelson, A. E., Wolf, D. M., Kaisho, T., Bogunovic, D., Bhardwaj, N., & Krummel, M. F. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.003 · Cited by 1,026
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0085-8 · Cited by 1,021
Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Garris, C. S., Arlauckas, S. P., Kohler, R. H., Trefny, M. P., Garren, S., Piot, C., Engblom, C., Pfirschke, C., Siwicki, M., Gungabeesoon, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.024 · Cited by 966
Self-citationIn Vivo Analysis of Dendritic Cell Development and Homeostasis
Liu, K., Victora, G. D., Schwickert, T. A., Guermonprez, P., Meredith, M. M., Yao, K., Chu, F.-F., Randolph, G. J., Rudensky, A. Y., & Nussenzweig, M. (2009) · Science · doi:10.1126/science.1170540 · Cited by 952
A conserved dendritic-cell regulatory program limits antitumour immunity
Maier, B., Leader, A. M., Chen, S. T., Tung, N., Chang, C., LeBerichel, J., Chudnovskiy, A., Maskey, S., Walker, L., Finnigan, J. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2134-y · Cited by 941
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Bassez, A., Vos, H., Van Dyck, L., Floris, G., Arijs, I., Desmedt, C., Boeckx, B., Vanden Bempt, M., Nevelsteen, I., Lambein, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01323-8 · Cited by 867
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Cheever, M. A., & Higano, C. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3126 · Cited by 780
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes
Stoll, S., Delon, J., Brotz, T. M., & Germain, R. N. (2002) · Science · doi:10.1126/science.1071065 · Cited by 718
Itano, A. A., McSorley, S. J., Reinhardt, R. L., Ehst, B. D., Ingulli, E., Rudensky, A. Y., & Jenkins, M. K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00175-4 · Cited by 718
Chow, M. T., Ozga, A. J., Servis, R. L., Frederick, D. T., Lo, J. A., Fisher, D. E., Freeman, G. J., Boland, G. M., & Luster, A. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.010 · Cited by 716
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Binnewies, M., Mujal, A. M., Pollack, J. L., Combes, A. J., Hardison, E. A., Barry, K. C., Tsui, J., Ruhland, M. K., Kersten, K., Abushawish, M. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.005 · Cited by 629
Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
Bousso, P., & Robey, E. (2003) · Nature Immunology · doi:10.1038/ni928 · Cited by 625
cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity
Ferris, S. T., Durai, V., Wu, R., Theisen, D. J., Ward, J. P., Bern, M. D., Davidson, J. T., Bagadia, P., Liu, T., Briseño, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2611-3 · Cited by 611
Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity
Brown, C. C., Gudjonson, H., Pritykin, Y., Deep, D., Lavallée, V.-P., Mendoza, A., Fromme, R., Mazutis, L., Ariyan, C., Leslie, C., et al. (2019) · Cell · doi:10.1016/j.cell.2019.09.035 · Cited by 601
Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes
Miller, M. J., Safrina, O., Parker, I., & Cahalan, M. D. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041236 · Cited by 545
CD40 agonist antibodies in cancer immunotherapy
Vonderheide, R. H. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-062518-045435 · Cited by 544
Antigen-Presentation Properties of Plasmacytoid Dendritic Cells
Villadangos, J. A., & Young, L. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.002 · Cited by 544
Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo
Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Maraver, A., Lafaille, J. J., & Dustin, M. L. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050783 · Cited by 527
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Kitajima, S., Ivanova, E., Guo, S., Yoshida, R., Campisi, M., Sundararaman, S. K., Tange, S., Mitsuishi, Y., Thai, T. C., Masuda, S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0689 · Cited by 526
Dutertre, C.-A., Becht, E., Irac, S. E., Khalilnezhad, A., Narang, V., Khalilnezhad, S., Ng, P. Y., van den Hoogen, L. L., Leong, J. Y., Lee, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.008 · Cited by 520
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3844 · Cited by 519
Engineering dendritic cell vaccines to improve cancer immunotherapy
Perez, C. R., & De Palma, M. (2019) · Nature Communications · doi:10.1038/s41467-019-13368-y · Cited by 505
Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy
Miller, M. J., Wei, S. H., Cahalan, M. D., & Parker, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628040100 · Cited by 494
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
Di Pilato, M., Kfuri-Rubens, R., Pruessmann, J. N., Ozga, A. J., Messemaker, M., Cadilha, B. L., Sivakumar, R., Cianciaruso, C., Warner, R. D., Marangoni, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.015 · Cited by 488
Self-citationHyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Hegde, S., Krisnawan, V. E., Herzog, B. H., Zuo, C., Breden, M. A., Knolhoff, B. L., Hogg, G. D., Tang, J. P., Baer, J. M., Mpoy, C., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.008 · Cited by 463
Dendritic Cell Regulation of T Helper Cells
Yin, X., Chen, S., & Eisenbarth, S. C. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-025146 · Cited by 447
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Hammerich, L., Marron, T. U., Upadhyay, R., Svensson-Arvelund, J., Dhainaut, M., Hussein, S., Zhan, Y., Ostrowski, D., Yellin, M., Marsh, H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0410-x · Cited by 436
Greter, M., Helft, J., Chow, A., Hashimoto, D., Mortha, A., Agudo-Cantero, J., Bogunovic, M., Gautier, E. L., Miller, J., Leboeuf, M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.027 · Cited by 433
Magen, A., Hamon, P., Fiaschi, N., Soong, B. Y., Park, M. D., Mattiuz, R., Humblin, E., Troncoso, L., D’souza, D., Dawson, T., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02345-0 · Cited by 429
Bosteels, C., Neyt, K., Vanheerswynghels, M., van Helden, M. J., Sichien, D., Debeuf, N., De Prijck, S., Bosteels, V., Vandamme, N., Martens, L., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.005 · Cited by 412
A neutrophil response linked to tumor control in immunotherapy
Gungabeesoon, J., Gort-Freitas, N. A., Kiss, M., Bolli, E., Messemaker, M., Siwicki, M., Hicham, M., Bill, R., Koch, P., Cianciaruso, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.032 · Cited by 412
Self-citationIsocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
Kohanbash, G., Carrera, D. A., Shrivastav, S., Ahn, B. J., Jahan, N., Mazor, T., Chheda, Z. S., Downey, K. M., Watchmaker, P. B., Beppler, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90644 · Cited by 410
Spranger, S., Luke, J. J., Bao, R., Zha, Y., Hernandez, K. M., Li, Y., Gajewski, A. P., Andrade, J., & Gajewski, T. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609376113 · Cited by 399
Henrickson, S. E., Mempel, T. R., Mazo, I. B., Liu, B., Artyomov, M. N., Zheng, H., Peixoto, A., Flynn, M. P., Senman, B., Junt, T., et al. (2008) · Nature Immunology · doi:10.1038/ni1559 · Cited by 394
Self-citationLe Borgne, M., Etchart, N., Goubier, A., Lira, S. A., Sirard, J. C., van Rooijen, N., Caux, C., Aït-Yahia, S., Vicari, A., Kaiserlian, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.005 · Cited by 392
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Zitvogel, L., Kepp, O., Senovilla, L., Menger, L., Chaput, N., & Kroemer, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2891 · Cited by 387
Duong, E., Fessenden, T. B., Lutz, E., Dinter, T., Yim, L., Blatt, S., Bhutkar, A., Wittrup, K. D., & Spranger, S. (2022) · Immunity · doi:10.1016/j.immuni.2021.10.020 · Cited by 372
Prokhnevska, N., Cardenas, M. A., Valanparambil, R. M., Sobierajska, E., Barwick, B. G., Jansen, C., Reyes Moon, A., Gregorova, P., delBalzo, L., Greenwald, R., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.12.002 · Cited by 365
Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity
Hugues, S., Fetler, L., Bonifaz, L., Helft, J., Amblard, F., & Amigorena, S. (2004) · Nature Immunology · doi:10.1038/ni1134 · Cited by 358
Brewitz, A., Eickhoff, S., Dähling, S., Quast, T., Bedoui, S., Kroczek, R. A., Kurts, C., Garbi, N., Barchet, W., Iannacone, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.003 · Cited by 339
Braun, A., Worbs, T., Moschovakis, G. L., Halle, S., Hoffmann, K., Bölter, J., Münk, A., & Förster, R. (2011) · Nature Immunology · doi:10.1038/ni.2085 · Cited by 337
Robust Anti-Viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
Eickhoff, S., Brewitz, A., Gerner, M. Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R. N., & Kastenmüller, W. (2015) · Cell · doi:10.1016/j.cell.2015.08.004 · Cited by 337
Shakhar, G., Lindquist, R. L., Skokos, D., Dudziak, D., Huang, J. H., Nussenzweig, M. C., & Dustin, M. L. (2005) · Nature Immunology · doi:10.1038/ni1210 · Cited by 331
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Osada, T., Chong, G., Tansik, R., Hong, T., Spector, N., Kumar, R., Hurwitz, H. I., Dev, I., Nixon, A. B., Lyerly, H. K., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0441-x · Cited by 311
Veglia, F., Tyurin, V. A., Mohammadyani, D., Blasi, M., Duperret, E. K., Donthireddy, L., Hashimoto, A., Kapralov, A., Amoscato, A., Angelini, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02186-9 · Cited by 308
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Saxena, M., & Bhardwaj, N. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.007 · Cited by 305
Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
Rodrigues, P. F., Alberti-Servera, L., Eremin, A., Grajales-Reyes, G. E., Ivanek, R., & Tussiwand, R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0136-9 · Cited by 301
Hor, J. L., Whitney, P. G., Zaid, A., Brooks, A. G., Heath, W. R., & Mueller, S. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.020 · Cited by 285
CXCL12-CXCR4 Engagement Is Required for Migration of Cutaneous Dendritic Cells
Kabashima, K., Shiraishi, N., Sugita, K., Mori, T., Onoue, A., Kobayashi, M., Sakabe, J.-I., Yoshiki, R., Tamamura, H., Fujii, N., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070225 · Cited by 268
Human dendritic cells in cancer
Kvedaraite, E., & Ginhoux, F. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm9409 · Cited by 257
Kobie, J. J., Wu, R. S., Kurt, R. A., Lou, S., Adelman, M. K., Whitesell, L. J., Ramanathapuram, L. V., Arteaga, C. L., & Akporiaye, E. T. (2003) · PubMed · Cited by 251
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Gerhard, G. M., Bill, R., Messemaker, M., Klein, A. M., & Pittet, M. J. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200264 · Cited by 247
Self-citationDendritic cells and monocyte-derived cells: Two complementary and integrated functional systems
Schlitzer, A., McGovern, N., & Ginhoux, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.011 · Cited by 244
Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
Ruhland, M. K., Roberts, E. W., Cai, E., Mujal, A. M., Marchuk, K., Beppler, C., Nam, D., Serwas, N. K., Binnewies, M., & Krummel, M. F. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.002 · Cited by 240
Dendritic cells direct circadian anti-tumour immune responses
Wang, C., Barnoud, C., Cenerenti, M., Sun, M., Caffa, I., Kizil, B., Bill, R., Liu, Y., Pick, R., Garnier, L., et al. (2023) · Nature · doi:10.1038/s41586-022-05605-0 · Cited by 238
Self-citationTze, L. E., Horikawa, K., Domaschenz, H., Howard, D. R., Roots, C. M., Rigby, R. J., Way, D. A., Ohmura-Hoshino, M., Ishido, S., Andoniou, C. E., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20092203 · Cited by 232
Meyer, M. A., Baer, J. M., Knolhoff, B. L., Nywening, T. M., Panni, R. Z., Su, X., Weilbaecher, K. N., Hawkins, W. G., Ma, C., Fields, R. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03600-6 · Cited by 217
Targeting innate immune pathways for cancer immunotherapy
Cao, L. L., & Kagan, J. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.018 · Cited by 216
Bayerl, F., Meiser, P., Donakonda, S., Hirschberger, A., Lacher, S. B., Pedde, A.-M., Hermann, C. D., Elewaut, A., Knolle, M., Ramsauer, L., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.011 · Cited by 203
Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1047 · Cited by 199
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells
Sen Santara, S., Lee, D.-J., Crespo, Â., Hu, J. J., Walker, C., Ma, X., Zhang, Y., Chowdhury, S., Meza-Sosa, K. F., Lewandrowski, M., et al. (2023) · Nature · doi:10.1038/s41586-023-05912-0 · Cited by 187
Canton, J., Blees, H., Henry, C. M., Buck, M. D., Schulz, O., Rogers, N. C., Childs, E., Zelenay, S., Rhys, H., Domart, M.-C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00824-x · Cited by 181
Dendritic cell and antigen dispersal landscapes regulate T cell immunity
Gerner, M. Y., Casey, K. A., Kastenmuller, W., & Germain, R. N. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170335 · Cited by 180
Dahan, R., Barnhart, B. C., Li, F., Yamniuk, A. P., Korman, A. J., & Ravetch, J. V. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.001 · Cited by 165
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control
Steele, M. M., Jaiswal, A., Delclaux, I., Dryg, I. D., Murugan, D., Femel, J., Son, S., du Bois, H., Hill, C. M., Leachman, S. A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01443-y · Cited by 146
Henrickson, S. E., Perro, M., Loughhead, S. M., Senman, B. C., Stutte, S., Quigley, M. M., Alexe, G., Iannacone, M., Flynn, M. P., Omid, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.034 · Cited by 145
Self-citationMittal, D., Vijayan, D., Putz, E. M., Aguilera, A. R., Markey, K. A., Straube, J., Kazakoff, S. H., Nutt, S. L., Takeda, K., Hill, G. R., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0341 · Cited by 139
NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity
Ghislat, G., Cheema, A. S., Baudoin, E., Verthuy, C., Ballester, P. J., Crozat, K., Attaf, N., Dong, C., Milpied, P., MALISSEN, B., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg3570 · Cited by 139
Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node
Kitano, M., Yamazaki, C., Takumi, A., Ikeno, T., Hemmi, H., Takahashi, N. K., Shimizu, K., Fraser, S. E., Hoshino, K., Kaisho, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513607113 · Cited by 130
Human Tumor Antigens Yesterday, Today, and Tomorrow
Finn, O. J. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0112 · Cited by 126
Cabeza-Cabrerizo, M., van Blijswijk, J., Wienert, S., Heim, D., Jenkins, R. P., Chakravarty, P., Rogers, N. C., Frederico, B., Acton, S. E., Beerling, E., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw1941 · Cited by 125
Roles of the RANKL–RANK axis in antitumour immunity — implications for therapy
Ahern, E. S., Smyth, M. J., Dougall, W. C., & Teng, M. W. L. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0095-y · Cited by 122
Sokol, C. L., Camire, R. B., Jones, M. C., & Luster, A. D. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.012 · Cited by 114
CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes
Rawat, K., Tewari, A., Li, X., Mara, A. B., King, W. T., Gibbings, S. L., Nnam, C. F., Kolling, F., Lambrecht, B. N., & Jakubzick, C. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20222129 · Cited by 110
Ho, W. W., Gomes-Santos, I. L., Aoki, S., Datta, M., Kawaguchi, K., Talele, N. P., Roberge, S., Ren, J. P., Liu, H., Chen, I. X., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105323118 · Cited by 102
Self-citationIngulli, E. G., Ulman, D. R., Lucido, M. M., & Jenkins, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2247 · Cited by 94
Salomon, R., Rotem, H., Katzenelenbogen, Y., Weiner, A., Saban, N. C., Feferman, T., Amit, I., & Dahan, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00329-6 · Cited by 83
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens
Squadrito, M. L., Cianciaruso, C., Hansen, S. K., & Palma, M. D. (2018) · Nature Methods · doi:10.1038/nmeth.4579 · Cited by 81
Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens
Lind, E. F., Ahonen, C. L., Wasiuk, A., Kosaka, Y., Becher, B., Bennett, K. A., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.354 · Cited by 62
Reclassifying plasmacytoid dendritic cells as innate lymphocytes
Ziegler‐Heitbrock, L., Ohteki, T., Ginhoux, F., Shortman, K., & Spits, H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00806-0 · Cited by 58
Recruitment of dendritic cell progenitors to foci of influenza A virus infection sustains immunity
Cabeza-Cabrerizo, M., Minutti, C. M., da Costa, M. P., Cardoso, A., Jenkins, R. P., Kulikauskaite, J., Buck, M. D., Piot, C., Rogers, N. C., Crotta, S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi9331 · Cited by 53
Dendritic cells require NIK for CD40-dependent cross-priming of CD8 + T cells
Katakam, A. K., Brightbill, H. D., Franci, C., Kung, C., Núñez, V., Jones, C., Peng, I., Jeet, S., Wu, L. C., Mellman, I., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520627112 · Cited by 52
Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks
Ugur, M., Labios, R. J., Fenton, C., Knöpper, K., Jobin, K., Imdahl, F., Golda, G., Hoh, K., Grafen, A., Kaisho, T., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.020 · Cited by 52
Pfirschke, C., Žilionis, R., Engblom, C., Messemaker, M., Zou, A. E., Rickelt, S., Gort-Freitas, N. A., Lin, Y., Bill, R., Siwicki, M., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0326 · Cited by 48
Self-citationLugani, S., Halabi, E. A., Oh, J., Köhler, R. H., Peterson, H. M., Breakefield, X. O., Chiocca, E. A., Miller, M. A., Garris, C., & Weissleder, R. (2022) · Advanced Materials · doi:10.1002/adma.202208782 · Cited by 46
Self-citationDifferential chemokine receptor expression and usage by pre‐ cDC 1 and pre‐ cDC 2
Cook, S. J., Lee, Q., Wong, A. C. H., Spann, B. C., Vincent, J. N., Wong, J. J. L., Schlitzer, A., Gorrell, M. D., Weninger, W., & Roediger, B. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12186 · Cited by 35
MacNabb, B. W., Chen, X., Tumuluru, S., Godfrey, J., Kasal, D. N., Yu, J., Jongsma, M. L. M., Spaapen, R. M., Kline, D. E., & Kline, J. (2022) · Immunity · doi:10.1016/j.immuni.2022.09.015 · Cited by 35
Dendritic cell cross‐dressing and tumor immunity
Martínez-Usatorre, A., & Palma, M. D. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216523 · Cited by 33
IL-6 selectively suppresses cDC1 specification via C/EBPβ
Kim, S. K., Chen, J., Jo, S., Ou, F., Ferris, S. T., Liu, T., Ohara, R. A., Anderson, D. A., Wu, R., Chen, M., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221757 · Cited by 32
Hoefsmit, E. P., van Royen, P. T., Rao, D., Stunnenberg, J. A., Dimitriadis, P., Lieftink, C., Morris, B., Rozeman, E. A., Reijers, I. L. M., Lacroix, R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0494 · Cited by 23
Koch, P. D., Rodell, C. B., Köhler, R. H., Pittet, M. J., & Weissleder, R. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2019.12.007 · Cited by 22
Self-citationcIAP1/2 Antagonism Induces Antigen-Specific T Cell–Dependent Immunity
Ventre, K. S., Roehle, K., Bello, E., Bhuiyan, A. M., Biary, T., Crowley, S. J., Bruck, P. T., Heckler, M., Lenehan, P. J., Ali, L. R., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200646 · Cited by 13
To, T. K. J., Devalaraja, S., Folkert, I. W., Zhai, L., Lobel, G. P., & Haldar, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.13.507746 · Cited by 4
Victora, G. D., Chudnovskiy, A., Nakandakari-Higa, S., Castro, T. B. R., Cui, A., Lin, C., Sade-Feldman, M., Phillips, B. K., Pae, J., Mesin, L., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2152423/v1 · Cited by 2
Cited by
The cancer-immunity cycle: Indication, genotype, and immunotype
Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.011 · Cited by 953
CD8+ T cells in the cancer-immunity cycle
Giles, J. R., Globig, A.-M., Kaech, S. M., & Wherry, E. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.005 · Cited by 449
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Heras-Murillo, I., Adán-Barrientos, I., Galán, M., Wculek, S. K., & Sancho, D. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00859-1 · Cited by 383
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes
Alraies, Z., Rivera, C. A., Delgado, M.-G., Sanséau, D., Maurin, M., Amadio, R., Maria Piperno, G., Dunsmore, G., Yatim, A., Lacerda Mariano, L., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01856-3 · Cited by 106
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Pittet, M. J., Di Pilato, M., Garris, C., & Mempel, T. R.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 56
- Issue
- 10
- Pages
- 2218-2230
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W4386709479
- Cited by
- 313
- References
- 126
- FWCI
- 27.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.